EP1109887A4 - Production et utilisation de cellules dopaminergiques pour traiter des deficiences dopaminergiques - Google Patents

Production et utilisation de cellules dopaminergiques pour traiter des deficiences dopaminergiques

Info

Publication number
EP1109887A4
EP1109887A4 EP98959412A EP98959412A EP1109887A4 EP 1109887 A4 EP1109887 A4 EP 1109887A4 EP 98959412 A EP98959412 A EP 98959412A EP 98959412 A EP98959412 A EP 98959412A EP 1109887 A4 EP1109887 A4 EP 1109887A4
Authority
EP
European Patent Office
Prior art keywords
dopaminergic
production
treat
deficiencies
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98959412A
Other languages
German (de)
English (en)
Other versions
EP1109887A1 (fr
Inventor
Michael P Mcgrogan
Gary L Snable
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Layton Bioscience Inc
Original Assignee
Layton Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Layton Bioscience Inc filed Critical Layton Bioscience Inc
Publication of EP1109887A1 publication Critical patent/EP1109887A1/fr
Publication of EP1109887A4 publication Critical patent/EP1109887A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0271—Chimeric animals, e.g. comprising exogenous cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/48—Regulators of apoptosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/24—Genital tract cells, non-germinal cells from gonads
    • C12N2502/246—Cells of the male genital tract, non-germinal testis cells
EP98959412A 1998-07-29 1998-11-10 Production et utilisation de cellules dopaminergiques pour traiter des deficiences dopaminergiques Withdrawn EP1109887A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9451598P 1998-07-29 1998-07-29
US94515P 1998-07-29
PCT/US1998/023977 WO2000006700A1 (fr) 1998-07-29 1998-11-10 Production et utilisation de cellules dopaminergiques pour traiter des deficiences dopaminergiques

Publications (2)

Publication Number Publication Date
EP1109887A1 EP1109887A1 (fr) 2001-06-27
EP1109887A4 true EP1109887A4 (fr) 2003-05-21

Family

ID=22245637

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98959412A Withdrawn EP1109887A4 (fr) 1998-07-29 1998-11-10 Production et utilisation de cellules dopaminergiques pour traiter des deficiences dopaminergiques

Country Status (2)

Country Link
EP (1) EP1109887A4 (fr)
WO (1) WO2000006700A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004065599A1 (fr) * 2003-01-24 2004-08-05 Eisai Co., Ltd. Lrp4/corine, marqueur de cellules precurseurs de la proliferation de neurones produisant de la dopamine
WO2006009241A1 (fr) 2004-07-22 2006-01-26 Eisai Co., Ltd. MARQUEUR DE CELLULE PRÉCURSEUR DE NEURONE, PRODUISANT DE LA DOPAMINE Lrp4/CORINE
CN101292031A (zh) 2005-08-18 2008-10-22 卫材R&D管理有限公司 多巴胺能神经元增殖祖细胞的标记物Nato3
JP5775667B2 (ja) * 2006-11-01 2015-09-09 ラトガース， ザ ステイト ユニバーシティー オブ ニュージャージー 臍帯血幹細胞の増殖および成長因子産生のリチウム刺激の方法
JP6090937B2 (ja) 2011-07-27 2017-03-08 国立大学法人京都大学 新規ドーパミン産生神経前駆細胞マーカー

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006757A1 (fr) * 1988-12-15 1990-06-28 The Regents Of The University Of California Greffe de cellules genetiquement modifiees pour le traitement de maladies du systeme nerveux central
WO1994010292A1 (fr) * 1992-10-28 1994-05-11 Neurospheres Ltd. Facteurs biologiques et cellules souches neurales
WO1996015224A1 (fr) * 1994-11-14 1996-05-23 Neurospheres Holdings Ltd. Induction in vitro de cellules dopaminergiques
WO1997033470A1 (fr) * 1996-03-12 1997-09-18 University Of South Florida Procede et support ameliorant la viabilite, la maturation et la cryopreservation des cellules

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175103A (en) * 1991-10-21 1992-12-29 Trustees Of University Of Pennsylvania Preparation of pure cultures of post-mitotic human neurons

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006757A1 (fr) * 1988-12-15 1990-06-28 The Regents Of The University Of California Greffe de cellules genetiquement modifiees pour le traitement de maladies du systeme nerveux central
WO1994010292A1 (fr) * 1992-10-28 1994-05-11 Neurospheres Ltd. Facteurs biologiques et cellules souches neurales
WO1996015224A1 (fr) * 1994-11-14 1996-05-23 Neurospheres Holdings Ltd. Induction in vitro de cellules dopaminergiques
WO1997033470A1 (fr) * 1996-03-12 1997-09-18 University Of South Florida Procede et support ameliorant la viabilite, la maturation et la cryopreservation des cellules

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
LAYTONBIO: "Press releases number: 24, 26, 27, 28, 29, 30, 31(a) to (k)", HTTP://WWW.LAYTONBIO.COM/WHATSNEW.HTM, 9 March 1999 (1999-03-09), XP002199748 *
MENA MARIA ANGELES ET AL: "Effects of dibutyryl cyclic AMP and retinoic acid on the differentiation of dopamine neurons: Prevention of cell death by dibutyryl cyclic AMP.", JOURNAL OF NEUROCHEMISTRY, vol. 65, no. 6, 1995, pages 2612 - 2620, XP009001318, ISSN: 0022-3042 *
PLEASURE S J ET AL: "PURE, POSTMITOTIC, POLARIZED HUMAN NEURONS DERIVED FROM NTERA 2 CELLS PROVIDE A SYSTEM FOR EXPRESSING EXOGENOUS PROTEINS IN TERMINALLY DIFFERENTIATED NEURONS", JOURNAL OF NEUROSCIENCE, NEW YORK, NY, US, vol. 12, no. 5, May 1992 (1992-05-01), pages 1802 - 1815, XP002915302, ISSN: 0270-6474 *
See also references of WO0006700A1 *
TERAO T ET AL: "LITHIUM CHLORIDE STIMULATES CATECHOLAMINE SYNTHESIS AND SECRETION IN CULTURED BOVINE ADRENAL MEDULLARY CELLS", BIOLOGICAL PSYCHIATRY, vol. 31, no. 10, 1992, pages 1038 - 1049, XP009001664, ISSN: 0006-3223 *

Also Published As

Publication number Publication date
WO2000006700A1 (fr) 2000-02-10
EP1109887A1 (fr) 2001-06-27

Similar Documents

Publication Publication Date Title
US5670047B1 (en) Anaerobic treatment process for the rapid hydrolysis and conversion of organic materials to soluble and gaseous components
PL335933A1 (en) Highly permeable insert of improved collection and distribution power
IT1299162B1 (it) Assieme protesico da impiegarsi nelle terapie chirurgiche del prolasso urogenitale
HUP0202705A3 (en) Methods and microorganisms or production of panto-compounds
IL149175A0 (en) Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
AU5482599A (en) Human mesencephalon cell lines and methods of use therefor
HUP0002100A3 (en) The use of alpha-methyl-p-tyrosine to inhibit melanin production in iris melanocytes
TJ347B (en) Cryptophicin compounds pharmacentical composition method to inhibit the proliteration of cells and and method to treat neoplasia
GB9912159D0 (en) Improvements in and relating to the treatment of water
AU2479099A (en) Topical vasodilatory gel composition and methods of use and production
IL150125A0 (en) Novel compounds
EP1109887A4 (fr) Production et utilisation de cellules dopaminergiques pour traiter des deficiences dopaminergiques
GB9814036D0 (en) Materials and methods relating to the induction of apoptosis in target cells
ID18154A (id) Amplop dapat digunakan kembali yang mudah dibuka
PL327815A1 (en) Fabric subject to treatment with cellulase and oxyrecuctase
AU2002251681A1 (en) Production and use of dopaminergic cells to treat dopaminergic deficiencies
GB9912639D0 (en) Improvements in and relating to treatment of respiratory conditions
EP0796322A4 (fr) Production et utilisation de methyltransferases de l'homme et des plantes
GB9721075D0 (en) Materials and methods relating to the stimulation of cells
GB2337153B (en) Improvements in and relating to the collection of ions
GB9606415D0 (en) Improvements in and relating to the generation of elecricity
AU5144299A (en) Production and use of modified cystatins
GB9622100D0 (en) Improvements in and relating to the production of hydrogen
GB9621948D0 (en) Improvements in and relating to the production of hydrogen
SG66450A1 (en) Method of layering cache and architectural specific functions to facilitate design extension

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010226

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IE IT LI NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030402

17Q First examination report despatched

Effective date: 20040706

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060601